Alkermes | Results Presentation Deck | 26 slides

Alkermes · 2022-06
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

26
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Situation & Context
02
other
Open slide detailBeat · Situation & Context
03
front_matter
Open slide detailBeat · Situation & Context
04
front_matter
Open slide detailBeat · Situation & Context
05
The slide uses a screenshot of a medical journal article abstract to provide authority for the claims made in the bullet points.cite_precedent
Open slide detailBeat · Problem & Complication
06
The diagram illustrates the binding affinity of Nemvaleukin to the beta/gamma receptor complex (CD122/CD132) while avoiding the alpha receptor (CD25).present_solution
Open slide detailBeat · Problem & Complication
07
The slide uses a visual representation of protein engineering (IL-2 + IL-2Ra -> Nemvaleukin).present_solution
Open slide detailBeat · Solution & Approach
08
RP2D stands for Recommended Phase 2 Dose.summarize
Open slide detailBeat · Solution & Approach
09
Clinical trial design diagram showing study flow and patient population metrics.present_framework
Open slide detailBeat · Evidence & ProofLoop · Aha Moment
10
The slide outlines the study structure and patient cohorts for a Phase 1/2 clinical trial.present_framework
Open slide detailBeat · Evidence & ProofLoop · Aha Moment
11
introduce_nominees
Open slide detailBeat · Evidence & ProofLoop · Aha Moment
12
transition
Open slide detailBeat · Evidence & ProofLoop · Aha Moment
13
Includes a swimmer plot (duration of treatment) and a clinical response table (ORR, DCR, DOR).analyze_data
Open slide detailBeat · Evidence & ProofLoop · Aha Moment
14
Includes a swimmer plot (swimmer chart) and a clinical response table. The swimmer plot tracks individual patient treatment duration, response types, and ongoinanalyze_data
Open slide detailBeat · Evidence & ProofLoop · Aha Moment
15
transition
Open slide detailBeat · Evidence & ProofLoop · Golden Circle
16
Data cut off Oct 29, 2021. Includes specific patient outcomes for ovarian, pancreatic, and esophageal cancers.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Golden Circle
17
Data cut off Oct 29, 2021. Includes abbreviations for tumor types and response categories.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Golden Circle
18
transition
Open slide detailBeat · Evidence & ProofLoop · Golden Circle
19
Diverging bar chart showing Grade 1-2 and Grade 3-4 events for two cohorts.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Golden Circle
20
The slide uses a human body diagram to map response locations to specific cancer types.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Golden Circle
21
front_matter
Open slide detailBeat · Impact & Next StepsLoop · Quick Win Big Bet
22
The slide uses a checkmark-list format to summarize four key clinical trial outcomes.summarize
Open slide detailBeat · Impact & Next StepsLoop · Quick Win Big Bet
23
The table uses checkmarks and crosses to compare clinical and molecular attributes across seven different drug candidates.compare_peers
Open slide detailBeat · Impact & Next StepsLoop · Quick Win Big Bet
24
The slide uses a grid-based layout to map clinical trials to strategic objectives.present_solution
Open slide detailBeat · Impact & Next StepsLoop · Quick Win Big Bet
25
state_next_steps
Open slide detailBeat · Impact & Next StepsLoop · Quick Win Big Bet
26
other
Open slide detailBeat · Impact & Next StepsLoop · Quick Win Big Bet